| 1. | | Recruiting | Dose Escalation Study with QLT0074 for Benign Prostatic Hyperplasia
Condition: Benign Prostatic Hyperplasia |
| 2. | | Terminated | A Double-Blind, Randomized, Placebo-Controlled, Multicenter, Phase III Study of Tariquidar + Paclitaxel/Carboplatin as First-Line Therapy in Non-Small Cell Lung Cancer (NSCLC)
Conditions: stage IIIB non-small cell lung cancer; stage IV non-small cell lung cancer |
| 3. | | Terminated | A Double-Blind, Randomized, Placebo-Controlled, Multicenter, Phase III Study of Tariquidar + Vinorelbine as First-Line Therapy in Non-Small Cell Lung Cancer (NSCLC)
Conditions: stage IIIB non-small cell lung cancer; stage IV non-small cell lung cancer |
| 4. | | Terminated | Phase II Study to Evaluate Tariquidar (XR9576), a Selective MDR-1 Inhibitor, in Chemotherapy Resistant Advanced Breast Cancer
Condition: Breast Neoplasms |
| 5. | | No longer recruiting | Photodynamic Therapy in Treating Patients With Stage III or Stage IV Melanoma
Conditions: Stage IV Melanoma; stage III melanoma; Recurrent Melanoma |
| 6. | | Terminated | Two studies to determine if verteporfin PDT is effective & safe in treating multiple basal cell carcinoma of the skin.
Conditions: Basal Cell Carcinoma; Nevoid Basal Cell Carcinoma Syndrome; Gorlin Syndrome |
